← Back to Patent Explorer
US4277487A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 2-phenylamino-2-imidazolines as bradycardiacs

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1979-07-17
•
Granted: 1981-07-07
•
Expires: 1999-07-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula <IMAGE> wherein R1 and R2, which may be the same or different, represent a hydrogen atom, a chlorine atom, or a methyl group, with the proviso that not both R1 and R2 are hydrogen, and R represents a radical selected from the group consisting of -(CH2)2 -C(CH3)=CH2, -(CH2)2-CH=CH2, -O-CH2-CH=CH2, -O-(CH2)2-CH=CH2, -O-CH2-C(CH3)=CH2, -O-CH2-CH=CH-CH3, <IMAGE> <IMAGE> +TR <IMAGE> and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

Inventors

  • 👤 Helmut Stahle
  • 👤 Herbert Koppe
  • 👤 Werner Kummer
  • 👤 Walter Kobinger
  • 👤 Christian Lillie
  • 👤 Ludwig Pichler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 12:06
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/04; C07D233/28; C07D233/44; C07D233/50; A; A61; A61P; A61P9/00; A61P9/14

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 105 words
A compound of the formula ##STR19## wherein R 1 and R 2 , which may be the same or different, represent a hydrogen atom, a chlorine atom, or a methyl group, with the proviso that not both R 1 and R 2 are hydrogen, and R represents a radical selected from the group consisting of --(CH 2 ) 2 --C(CH 3 )═CH 2 , --(CH 2 ) 2 --CH═CH 2 , --O--CH 2 --CH═CH 2 , --O--(CH 2 ) 2 --CH═CH 2 , --O--CH 2 --C(CH 3 )═CH 2 , --O--CH 2 --CH═CH--CH 3 , ##STR20## or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 105 words
A compound of the formula ##STR19## wherein R 1 and R 2 , which may be the same or different, represent a hydrogen atom, a chlorine atom, or a methyl group, with the proviso that not both R 1 and R 2 are hydrogen, and R represents a radical selected from the group consisting of --(CH 2 ) 2 --C(CH 3 )═CH 2 , --(CH 2 ) 2 --CH═CH 2 , --O--CH 2 --CH═CH 2 , --O--(CH 2 ) 2 --CH═CH 2 , --O--CH 2 --C(CH 3 )═CH 2 , --O--CH 2 --CH═CH--CH 3 , ##STR20## or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 24 words
A bradycardiac pharmaceutical dosage unit composition consisting essentially of an inert pharmaceutical carrier and an effective bradycardiac amount of a compound of claim 1.
Claim 4
Dependent Claim 33 words
The method of slowing the heart rate of a warm-blooded animal in need thereof, which comprises perorally or parenterally administering to said animal an effective bradycardiac amount of a compound of claim 1.

References Cited (Backward Citations)

US3708485A Cited
DE2102733A1 Cited
US3850926A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-07-06 1985-01-05 1985-07-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-07-06 1989-01-05 1989-07-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-07-06 1993-01-05 1993-07-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag